Abstract
Central hypothyroidism (CH) is a rare cause of hypothyroidism generally related to a hypothalamic–pituitary disorder or arising as an iatrogenic complication. In adults, CH may be secondary to quantitative and/or qualitative alterations in thyroid-stimulating hormone (TSH) secretion. The disease is difficult to diagnose clinically because it lacks specific clinical signs and these may be masked by other anterior pituitary hormone secretion deficiencies. In patients with long-standing and marked CH, a diagnosis may be made based on low free T4 levels and normal, low or moderately increased TSH levels. In patients with early-stage or moderate CH, exploration of the circadian TSH cycle, determination of TSH response after a TRH test or recombinant TSH injection, estimation of TSH index, or evaluation of peripheral indexes of thyroid hormone metabolism may be required to establish a diagnosis. Regarding treatment, patients should receive levothyroxine replacement therapy, but hormone objectives during follow-up need to be precisely determined in order to reduce cardiovascular risks and to improve the quality of life of patients.
Similar content being viewed by others
References
Lania A, Persani L, Beck-Peccoz P (2008) Central hypothyroidism. Pituitary 11:181–186
Persani L (2012) Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 97:3068–3078
Tagami T, Kimura H, Ohtani S et al (2011) Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr J 58:449–457
Wardle CA, Fraser WD, Squire CR (2001) Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test. Lancet 357:1013–1014
Sell MA, Schott M, Tharandt L et al (2008) Functional central hypothyroidism in the elderly. Aging Clin Exp Res 20:207–210
Caron PJ, Nieman LK, Rose SR et al (1986) Deficient nocturnal surge of thyrotropin in central hypothyroidism. J Clin Endocrinol Metab 62:960–964
Rose SR, Manasco PK, Pearce S et al (1990) Hypothyroidism and deficiency of the nocturnal thyrotropin surge in children with hypothalamic–pituitary disorders. J Clin Endocrinol Metab 70:1750–1755
Persani L (1998) Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity. Thyroid 8:941–946
Horimoto M, Nishikawa M, Ishihara T et al (1995) Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3′-triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 80:1124–1128
Persani L, Ferretti E, Borgato S et al (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85:3631–3635
Beck-Peccoz P, Persani L (1994) Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 131:331–340
Beck-Peccoz P, Amr S, Menezes-Ferreira MM et al (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312:1085–1090
Caturegli P, Newschaffer C, Olivi A et al (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614
Bensing S, Hulting AL, Höög A, Ericson K, Kämpe O (2007) Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. J Endocrinol Invest 30:153–162
Yamamoto M, Iguchi G, Takeno R et al (2011) Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest 121:113–119
Juszczak A, Gupta A, Karavitaki N et al (2012) Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review. Eur J Endocrinol 167:1–5
Loeffler JS, Shih HA (2011) Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 96:1992–2003
Littley MD, Shalet SM, Beardwell CG et al (1989) Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) 31:363–373
Brabant G, Toogood AA, Shalet SM et al (2012) Hypothyroidism following childhood cancer therapy: an under-diagnosed complication. Int J Cancer 130:1145–1150
Kokshoorn NE, Wassenaar MJ, Biermasz NR et al (2010) Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values. Eur J Endocrinol 162:11–18
Tanriverdi F, De Bellis A, Battaglia M et al (2010) Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? Eur J Endocrinol 162:861–867
Daffara F, De Francia S, Reimondo G et al (2008) Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. Endocr Relat Cancer 15:1043–1053
Zatelli MC, Gentilin E, Daffara F et al (2010) Therapeutic concentrations of mitotane (o, p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology 151:2453–2461
Sharma V, Hays WR, Wood WM et al (2006) Effects of rexinoids on thyrotrope function and the hypothalamic–pituitary–thyroid axis. Endocrinology 147:1438–1451
Haugen BR (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23:793–800
Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J (1994) Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol 41:609–614
Agha A, Walker D, Perry L et al (2007) Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol 66:72–77
Vigersky RA, Filmore-Nassar A, Glass AR (2006) Thyrotropin suppression by metformin. J Clin Endocrinol Metab 91:225–227
Cappelli C, Rotondi M, Pirola I et al (2009) TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 32:1589–1590
Cappelli C, Rotondi M, Pirola I et al (2012) Thyreotropin levels in diabetic patients on metformin treatment. Eur J Endocrinol 167:261–265
Lupoli R, Di Minno A, Tortora A, Ambrosino P, Arianna Lupoli G, Di Minno MN (2014) Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J Clin Endocrinol Metab 99:E143–E148
Lopez M, Varela L, Vasquez MJ et al (2010) Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 16:1001–1008
Brenta G, Danzi S, Klein I (2007) Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab 3:632–640
Alkemade A, Unmehopa UA, Wiersinga WM et al (2005) Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab 90:323–327
Collu R, Tang J, Castagné J et al (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82:1561–1565
Bonomi M, Busnelli M, Beck-Peccoz P et al (2009) A family with complete resistance to thyrotropin-releasing hormone. N Engl J Med 360:731–734
Medeiros-Neto G, Herodotou DT, Rajan S et al (1996) A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 97:1250–1256
Brumm H, Pfeufer A, Biebermann H, Schnabel D, Deiss D, Grüters A (2002) Congenital central hypothyroidism due to homozygous thyrotropin beta 313 delta mutation is caused by a founder effect. J Clin Endocrinol Metab 87:4811–4816
Alatzoglou KS, Dattani MT (2009) Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev 85:705–712
Sun Y, Bak B, Schoenmakers N et al (2012) Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet 44:1375–1381
Joustra SD, Schoenmakers N, Persani L et al (2013) The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab 98:4942–4952
Alexopoulou O, Beguin C, De Nayer P et al (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150:1–8
Barbesino G, Sluss PM, Caturegli P (2012) Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis. J Clin Endocrinol Metab 97:345–350
Ferretti E, Persani L, Jaffrain-Rea ML et al (1999) Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924–929
Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P, Paracchi S (1973) Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 37:595–601
Yamakita N, Komaki T, Takao T et al (2001) Usefulness of thyrotropin (TSH)-releasing hormone test and nocturnal surge of TSH for diagnosis of isolated deficit of TSH secretion. J Clin Endocrinol Metab 86:1054–1060
Jostel A, Rydert WD, Shalet SM (2009) The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH index. Clin Endocrinol 71:529–534
Filipsson H, Nystrom E, Johannsson G (2008) Exploring the use of recombinant human TSH in the diagnosis of central hypothyroidism. Eur J Endocrinol 159:153–160
Doin FC, Rosa-Borges M, Martins MR et al (2012) Diagnosis of subclinical central hypothyroidism in patients with hypothalamic–pituitary disease by Doppler echocardiography. Eur J Endocrinol 166:631–640
Klose M, Marina D, Hartoft-Nielsen ML et al (2013) Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients. J Clin Endocrinol Metab 98:3802–3810
Slawik M, Klawitter B, Meiser E et al (2007) Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J Clin Endocrinol Metab 92:4115–4122
Koulouri O, Auldin MA, Agarwal R et al (2011) Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Clin Endocrinol (Oxf) 74:744–749
Beck-Peccoz P (2011) Treatment of central hypothyroidism. Clin Endocrinol 74:671–672
Shimon I, Cohen O, Lubetsky A et al (2002) Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Thyroid 12:823–827
Carrozza V, Csako G, Yanovski JA et al (1999) Levothyroxine replacement therapy in central hypothyroidism: a practice report. Pharmacotherapy 19:349–355
Porretti S, Giavoli C, Ronchi C et al (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T4 therapy become mandatory? J Clin Endocrinol Metab 87:2042–2045
Arafah BM (2001) Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344:1743–1749
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grunenwald, S., Caron, P. Central hypothyroidism in adults: better understanding for better care. Pituitary 18, 169–175 (2015). https://doi.org/10.1007/s11102-014-0559-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-014-0559-8